Published in Biochem J on July 01, 1996
Materials become insensitive to flaws at nanoscale: lessons from nature. Proc Natl Acad Sci U S A (2003) 6.22
Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. Am J Pathol (2004) 3.15
Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nat Rev Cancer (2008) 3.04
Phosphorylated proteins and control over apatite nucleation, crystal growth, and inhibition. Chem Rev (2008) 2.65
DMP1 depletion decreases bone mineralization in vivo: an FTIR imaging analysis. J Bone Miner Res (2005) 2.46
Rescue of odontogenesis in Dmp1-deficient mice by targeted re-expression of DMP1 reveals roles for DMP1 in early odontogenesis and dentin apposition in vivo. Dev Biol (2006) 2.00
Biomimetic systems for hydroxyapatite mineralization inspired by bone and enamel. Chem Rev (2008) 1.96
TGF-beta regulates the mechanical properties and composition of bone matrix. Proc Natl Acad Sci U S A (2005) 1.83
Functional grading of mineral and collagen in the attachment of tendon to bone. Biophys J (2009) 1.73
Spatially and temporally controlled biomineralization is facilitated by interaction between self-assembled dentin matrix protein 1 and calcium phosphate nuclei in solution. Biochemistry (2005) 1.68
Calcium orthophosphates: crystallization and dissolution. Chem Rev (2008) 1.67
Genetic basis for the evolution of vertebrate mineralized tissue. Proc Natl Acad Sci U S A (2004) 1.56
Mechanism by which MLO-A5 late osteoblasts/early osteocytes mineralize in culture: similarities with mineralization of lamellar bone. Calcif Tissue Int (2006) 1.44
Bone regeneration: molecular and cellular interactions with calcium phosphate ceramics. Int J Nanomedicine (2006) 1.40
Identification of the ice-binding surface on a type III antifreeze protein with a "flatness function" algorithm. Biophys J (1998) 1.35
Inhibition of hydroxyapatite formation by osteopontin phosphopeptides. Biochem J (2004) 1.33
Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes. Mol Metab (2014) 1.31
Osteopontin deficiency increases bone fragility but preserves bone mass. Bone (2010) 1.28
A peptide that inhibits hydroxyapatite growth is in an extended conformation on the crystal surface. Proc Natl Acad Sci U S A (1998) 1.25
Enzyme Directed Templating of Artificial Bone Mineral. Adv Mater (2009) 1.23
Biominerals--hierarchical nanocomposites: the example of bone. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 1.20
Modular peptides promote human mesenchymal stem cell differentiation on biomaterial surfaces. Acta Biomater (2009) 1.19
Recent progress in the treatment of vascular calcification. Kidney Int (2010) 1.18
Role of matrix vesicles in biomineralization. Biochim Biophys Acta (2009) 1.17
Amelogenin-collagen interactions regulate calcium phosphate mineralization in vitro. J Biol Chem (2010) 1.14
Primary structure and phosphorylation of dentin matrix protein 1 (DMP1) and dentin phosphophoryn (DPP) uniquely determine their role in biomineralization. Biomacromolecules (2011) 1.11
Tooth root dentin mineralization defects in a mouse model of hypophosphatasia. J Bone Miner Res (2013) 1.09
Diffusion systems for evaluation of biomineralization. Calcif Tissue Int (2004) 1.03
Developmental appearance of dentin matrix protein 1 during the early dentinogenesis in rat molars as identified by high-resolution immunocytochemistry. Histochem Cell Biol (2005) 1.00
The three-dimensional structure of bovine calcium ion-bound osteocalcin using 1H NMR spectroscopy. Biochemistry (2003) 0.98
Fetuin-A/albumin-mineral complexes resembling serum calcium granules and putative nanobacteria: demonstration of a dual inhibition-seeding concept. PLoS One (2009) 0.97
Role of glutaraldehyde in calcification of porcine aortic valve fibroblasts. Am J Pathol (1999) 0.96
Human dental pulp stem cells produce mineralized matrix in 2D and 3D cultures. Eur J Histochem (2010) 0.94
Effect of sustained gene delivery of platelet-derived growth factor or its antagonist (PDGF-1308) on tissue-engineered cementum. J Periodontol (2004) 0.94
NMR investigation of the role of osteocalcin and osteopontin at the organic-inorganic interface in bone. Langmuir (2013) 0.93
Expression of bone sialoprotein and osteopontin in breast cancer bone metastases. Clin Exp Metastasis (2000) 0.93
Growth factors regulate expression of mineral associated genes in cementoblasts. J Periodontol (2000) 0.92
Differential expression profiling of components associated with exoskeletal hardening in crustaceans. BMC Genomics (2008) 0.91
Tracking circadian rhythms of bone mineral deposition in murine calvarial organ cultures. J Bone Miner Res (2013) 0.90
Controlled release strategies for bone, cartilage, and osteochondral engineering--Part I: recapitulation of native tissue healing and variables for the design of delivery systems. Tissue Eng Part B Rev (2013) 0.90
The Role of Basic Amino Acids in the Molecular Recognition of Hydroxyapatite by Statherin using Solid State NMR. Surf Sci (2010) 0.90
Sparc protein is required for normal growth of zebrafish otoliths. J Assoc Res Otolaryngol (2008) 0.89
A crustacean Ca2+-binding protein with a glutamate-rich sequence promotes CaCO3 crystallization. Biochem J (2004) 0.88
Phosphoric acid esters cannot replace polyvinylphosphonic acid as phosphoprotein analogs in biomimetic remineralization of resin-bonded dentin. Dent Mater (2009) 0.88
Lower osteocalcin and osteopontin contents of the femoral head in hip fracture patients than osteoarthritis patients. Osteoporos Int (2010) 0.87
Confocal laser Raman microspectroscopy of biomineralization foci in UMR 106 osteoblastic cultures reveals temporally synchronized protein changes preceding and accompanying mineral crystal deposition. J Biol Chem (2008) 0.87
Effects of fixation and decalcification on the immunohistochemical localization of bone matrix proteins in fresh-frozen bone sections. Histochem Cell Biol (2005) 0.87
Overexpression of the PLAP-1 gene inhibits the differentiation of BMSCs into osteoblast-like cells. J Mol Histol (2014) 0.85
Water soluble bioactives of nacre mediate antioxidant activity and osteoblast differentiation. PLoS One (2013) 0.84
Phosphoserine--a convenient compound for modification of calcium phosphate bone cement collagen composites. J Mater Sci Mater Med (2004) 0.84
MBCP biphasic calcium phosphate granules and tissucol fibrin sealant in rabbit femoral defects: the effect of fibrin on bone ingrowth. J Mater Sci Mater Med (2005) 0.84
Matrix vesicles are carriers of bone morphogenetic proteins (BMPs), vascular endothelial growth factor (VEGF), and noncollagenous matrix proteins. J Bone Miner Metab (2008) 0.84
The role of organic proteins on the crack growth resistance of human enamel. Acta Biomater (2015) 0.83
The influence of surface mineral and osteopontin on the formation and function of murine bone marrow-derived osteoclasts. J Mater Sci Mater Med (2008) 0.83
Identification of osteopontin phosphorylation sites involved in bone remodeling and inhibition of pathological calcification. J Cell Biochem (2008) 0.83
Osteoblast response to zirconia-hybridized pyrophosphate-stabilized amorphous calcium phosphate. J Biomed Mater Res A (2006) 0.83
Post-translational modification of osteopontin: effects on in vitro hydroxyapatite formation and growth. Biochem Biophys Res Commun (2012) 0.82
Multifunctional ECM proteins in bone and teeth. Exp Cell Res (2014) 0.82
Demineralization-remineralization dynamics in teeth and bone. Int J Nanomedicine (2016) 0.81
Biomimetic remineralization of dentin. Dent Mater (2013) 0.81
Collagen osteoid-like model allows kinetic gene expression studies of non-collagenous proteins in relation with mineral development to understand bone biomineralization. PLoS One (2013) 0.81
An overview of osteocalcin progress. J Bone Miner Metab (2016) 0.81
Ablation of systemic phosphate-regulating gene fibroblast growth factor 23 (Fgf23) compromises the dentoalveolar complex. Anat Rec (Hoboken) (2010) 0.81
Proliferation and osteoblastic differentiation of bone marrow stem cells: comparison of vertebral body and iliac crest. Eur Spine J (2010) 0.81
Water Soluble Components of 'Osteocare' Promote Cell Proliferation, Differentiation, and Matrix Mineralization in Human Osteoblast-Like SaOS-2 Cells. Sci Pharm (2014) 0.81
Mineralization defects in cementum and craniofacial bone from loss of bone sialoprotein. Bone (2015) 0.80
Dentin sialophosphoprotein (DSPP) gene-silencing inhibits key tumorigenic activities in human oral cancer cell line, OSC2. PLoS One (2010) 0.80
Cell derived hierarchical assembly of a novel phosphophoryn-based biomaterial. Cells Tissues Organs (2008) 0.80
Biophysical characterization of synthetic amelogenin C-terminal peptides. Eur J Oral Sci (2012) 0.79
Dynamic light scattering study of inhibition of nucleation and growth of hydroxyapatite crystals by osteopontin. PLoS One (2013) 0.79
Treatment with α-lipoic acid enhances the bone healing after femoral fracture model of rats. Naunyn Schmiedebergs Arch Pharmacol (2014) 0.79
The Mineral-Collagen Interface in Bone. Calcif Tissue Int (2015) 0.79
X-ray crystal structure of bovine 3 Glu-osteocalcin. Biochemistry (2013) 0.78
Bioactive glass induced in vitro apatite formation on composite GBR membranes. J Mater Sci Mater Med (2008) 0.78
Biological regulation of bone quality. Curr Osteoporos Rep (2014) 0.77
Effects of Polygonatum sibiricum polysaccharide on the osteogenic differentiation of bone mesenchymal stem cells in mice. Int J Clin Exp Pathol (2015) 0.77
Rediscovering Hydrogel-Based Double-Diffusion Systems for Studying Biomineralization. CrystEngComm (2012) 0.77
Face-specific incorporation of osteopontin into urinary and inorganic calcium oxalate monohydrate and dihydrate crystals. Urol Res (2010) 0.77
Effects of serum protein on ionic exchange between culture medium and microporous hydroxyapatite and silicate-substituted hydroxyapatite. J Mater Sci Mater Med (2011) 0.77
The Role of Poly(Aspartic Acid) in the Precipitation of Calcium Phosphate in Confinement. J Mater Chem B Mater Biol Med (2013) 0.77
Establishment of Periodontal Ligament Cell Lines from Temperature-Sensitive Simian Virus 40 Large T-antigen Transgenic Rats. Cytotechnology (2004) 0.76
Effect of Galla chinensis on the remineralization of two bovine root lesions morphous in vitro. Int J Oral Sci (2012) 0.76
Mathematical model for bone mineralization. Front Cell Dev Biol (2015) 0.76
Transgenic expression of dentin phosphoprotein inhibits skeletal development. Eur J Histochem (2016) 0.76
Chimeric Protein Template-Induced Shape Control of Bone Mineral Nanoparticles and Its Impact on Mesenchymal Stem Cell Fate. Biomacromolecules (2015) 0.76
Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases. J Immunol Res (2016) 0.75
The evolution of eggshell cuticle in relation to nesting ecology. Proc Biol Sci (2016) 0.75
Mechanical evaluation of a tissue-engineered zone of calcification in a bone-hydrogel osteochondral construct. Comput Methods Biomech Biomed Engin (2013) 0.75
Structural studies of hydrated samples of amorphous calcium phosphate and phosphoprotein nanoclusters. Eur Biophys J (2016) 0.75
C-terminal amidation of an osteocalcin-derived peptide promotes hydroxyapatite crystallization. J Biol Chem (2013) 0.75
Flagellar display of bone-protein-derived peptides for studying peptide-mediated biomineralization. Langmuir (2012) 0.75
New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs). Nutrients (2015) 0.75
Overexpression of PLAP-1 in bone marrow stromal cells inhibits the rat critical-size skull defect repair. J Mol Histol (2015) 0.75
BRONJ-related jaw bone is associated with increased Dlx-5 and suppressed osteopontin-implication in the site-specific alteration of angiogenesis and bone turnover by bisphosphonates. Clin Oral Investig (2014) 0.75
The distribution of osteocalcin, degree of mineralization, and mechanical properties along the length of Cyprinus carpio rib bone. J Mater Sci Mater Med (2001) 0.75
Ultrastructural and biochemical aspects of matrix vesicle-mediated mineralization. Jpn Dent Sci Rev (2016) 0.75
Osteocalcin and osteonectin expression after double application of platelet-rich plasma in rabbits. J Istanb Univ Fac Dent (2016) 0.75
Teleost fish osteocalcin 1 and 2 share the ability to bind the calcium mineral phase. Fish Physiol Biochem (2013) 0.75
Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci U S A (1986) 5.34
Osteonectin, a bone-specific protein linking mineral to collagen. Cell (1981) 4.06
Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev (1989) 3.87
Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci U S A (1975) 3.46
Characterization of a gamma-carboxyglutamic acid-containing protein from bone. Proc Natl Acad Sci U S A (1976) 3.15
Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem J (1985) 2.55
Nucleation of hydroxyapatite by bone sialoprotein. Proc Natl Acad Sci U S A (1993) 2.50
Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Miner (1993) 2.16
Isolation, characterization, and biosynthesis of a phosphorylated glycoprotein from rat bone. J Biol Chem (1987) 2.08
Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation. Biochem J (1994) 2.04
The primary structure of a cell-binding bone sialoprotein. J Biol Chem (1988) 1.93
Calcium and collagen binding properties of osteopontin, bone sialoprotein, and bone acidic glycoprotein-75 from bone. J Biol Chem (1992) 1.74
Concentration-dependent effects of dentin phosphophoryn in the regulation of in vitro hydroxyapatite formation and growth. Bone Miner (1990) 1.70
Modulation of crystal formation by bone phosphoproteins: role of glutamic acid-rich sequences in the nucleation of hydroxyapatite by bone sialoprotein. Biochem J (1994) 1.63
Expression of bone sialoprotein (BSP) in developing human tissues. Calcif Tissue Int (1991) 1.62
Inhibition of hydroxyapatite crystal growth by bone-specific and other calcium-binding proteins. Biochemistry (1986) 1.57
Phosphoprotein modulation of apatite crystallization. Calcif Tissue Int (1980) 1.29
Association of an extracellular protein (chondrocalcin) with the calcification of cartilage in endochondral bone formation. J Cell Biol (1984) 1.28
Mineral induction by immobilized polyanionic proteins. Calcif Tissue Int (1989) 1.28
Nonocollagenous proteins of dentin. Isolation and partial characterization of rat dentin proteins and proteoglycans using a three-step preparative method. Coll Relat Res (1981) 1.26
Isolation and characterization of native adult osteonectin. J Biol Chem (1985) 1.22
The extracellular matrix of cartilage in the growth plate before and during calcification: changes in composition and degradation of type II collagen. Calcif Tissue Int (1992) 1.21
Structure, expression, and regulation of the major noncollagenous matrix proteins of bone. Clin Orthop Relat Res (1992) 1.17
Isolation and characterization of a 35,000 molecular weight subunit fetal cartilage matrix protein. J Biol Chem (1983) 1.16
Bovine dentin phosphophoryn: composition and molecular weight. Biochemistry (1983) 1.13
Phosphophoryns-major noncollagenous proteins of rat incisor dentin. Calcif Tissue Res (1978) 1.05
Characterization of porcine osteonectin extracted from foetal calvariae. Biochem J (1988) 1.04
Induction of bone-related proteins, osteocalcin and osteopontin, and their matrix ultrastructural localization with development of chondrocyte hypertrophy in vitro. J Cell Biochem (1993) 1.01
Effects of dentin phosphophoryn on precipitation of calcium phosphate in gel in vitro. Calcif Tissue Int (1987) 1.00
Osteonectin inhibiting de novo formation of apatite in the presence of collagen. Calcif Tissue Int (1989) 0.94
Characterization of porcine bone sialoprotein: primary structure and cellular expression. Matrix (1993) 0.94
Differences in composition of cell-attachment sialoproteins between dentin and bone. J Dent Res (1993) 0.93
Immunolocalization of gamma-carboxyglutamic acid containing proteins in developing rat bones. Coll Relat Res (1985) 0.92
Induction and inhibition of hydroxyapatite formation by rat dentine phosphoprotein in vitro. Arch Oral Biol (1988) 0.91
A study of bone proteins which can prevent hydroxyapatite formation. Metab Bone Dis Relat Res (1982) 0.91
Characterization of structural sequences in the chicken osteocalcin gene: expression of osteocalcin by maturing osteoblasts and by hypertrophic chondrocytes in vitro. J Bone Miner Res (1995) 0.89
The effect of osteocalcin on in vitro lipid-induced hydroxyapatite formation and seeded hydroxyapatite growth. Calcif Tissue Int (1985) 0.89
The effect of Gla-containing proteins on the precipitation of insoluble salts. Biochem Biophys Res Commun (1987) 0.88
Changes in osteonectin distribution and levels are associated with mineralization of the chicken tibial growth cartilage. Calcif Tissue Int (1990) 0.88
Effects of non-collagenous proteins on the formation of apatite in calcium beta-glycerophosphate solutions. Arch Oral Biol (1992) 0.87
Domain structure and sequence distribution in dentin phosphophoryn. Biochem J (1991) 0.86
Gas chromatographic mass spectrometric sequence determination of osteocalcin, a gamma-carboxyglutamic acid-containing protein from chicken bone. J Biol Chem (1981) 0.81
Effect of bound phosphoproteins and other organic phosphates on alkaline phosphatase-induced mineralization of collagenous matrices in vitro. Bone Miner (1993) 0.80
Immobilized DPP and other proteins modify OCP formation. Calcif Tissue Int (1993) 0.80
Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med (2000) 11.12
MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell (1999) 6.40
Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest (1997) 4.31
Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci U S A (1975) 3.46
Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest (1994) 3.30
Cartilage and diarthrodial joints as paradigms for hierarchical materials and structures. Biomaterials (1992) 3.10
Adherence of Borrelia burgdorferi to the proteoglycan decorin. Infect Immun (1995) 2.96
Lysolecithin and cell fusion. Nature (1970) 2.90
Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J Clin Invest (2001) 2.90
Decorin-binding adhesins from Borrelia burgdorferi. Mol Microbiol (1998) 2.85
Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation (1999) 2.73
Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest (1995) 2.67
Nucleation of hydroxyapatite by bone sialoprotein. Proc Natl Acad Sci U S A (1993) 2.50
Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose. J Biol Chem (1986) 2.50
Isolation of dermatan sulfate proteoglycans from mature bovine articular cartilages. J Biol Chem (1985) 2.39
Proteoglycans from bovine nasal cartilage. Properties of a soluble form of link protein. J Biol Chem (1979) 2.32
Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1. J Clin Invest (1989) 2.20
Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology. Arthritis Rheum (1987) 2.19
Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease. J Clin Invest (1992) 2.10
Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation. Biochem J (1994) 2.04
Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis Cartilage (2011) 1.89
The role of soft connective tissue in the breakdown of pig articular cartilage cultivated in the presence of complement-sufficient antiserum to pig erythrocytes. II. Distribution of immunoglobulin G (IgG). Int Arch Allergy Appl Immunol (1973) 1.89
Binding of the proteoglycan decorin to collagen type VI. J Biol Chem (1992) 1.83
Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J Clin Invest (2001) 1.78
Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest (1995) 1.77
Proteoglycans in health and disease: structures and functions. Biochem J (1986) 1.75
Evidence for altered synthesis of type II collagen in patients with osteoarthritis. J Clin Invest (1998) 1.66
Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum (1987) 1.66
Modulation of crystal formation by bone phosphoproteins: role of glutamic acid-rich sequences in the nucleation of hydroxyapatite by bone sialoprotein. Biochem J (1994) 1.63
Identification of a hyaluronic acid-binding protein that interferes with the preparation of high-buoyant-density proteoglycan aggregates from adult human articular cartilage. Biochem J (1985) 1.62
Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis. J Clin Invest (1999) 1.62
Osteocalcin: isolation, characterization, and detection. Methods Enzymol (1984) 1.62
An immunoelectron microscope study of the organization of proteoglycan monomer, link protein, and collagen in the matrix of articular cartilage. J Cell Biol (1982) 1.60
Localization of proteoglycan monomer and link protein in the matrix of bovine articular cartilage: An immunohistochemical study. J Histochem Cytochem (1980) 1.59
Changes in joint cartilage aggrecan after knee injury and in osteoarthritis. Arthritis Rheum (1999) 1.59
Ultrastructural immunolocalization of noncollagenous (osteopontin and osteocalcin) and plasma (albumin and alpha 2HS-glycoprotein) proteins in rat bone. J Bone Miner Res (1993) 1.58
Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Arthritis Rheum (2000) 1.57
Repair of partial-thickness defects in articular cartilage: cell recruitment from the synovial membrane. J Bone Joint Surg Am (1996) 1.55
Electron microscopic studies of cartilage proteoglycans. Direct evidence for the variable length of the chondroitin sulfate-rich region of proteoglycan subunit core protein. J Biol Chem (1982) 1.53
The heterogeneity of link proteins isolated from human articular cartilage proteoglycan aggregates. J Biol Chem (1982) 1.50
Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis. J Exp Med (1999) 1.49
Calcium-dependent alpha-helical structure in osteocalcin. Biochemistry (1982) 1.47
Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase. Arthritis Rheum (2000) 1.47
Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas. Nature (1978) 1.47
Age-related changes in the structure of proteoglycan link proteins present in normal human articular cartilage. Biochem J (1983) 1.46
Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells. Exp Cell Res (1996) 1.45
Direct evidence for active metalloproteinases mediating matrix degradation in interleukin 1-stimulated human articular cartilage. Matrix (1993) 1.42
The immunologic detection and characterization of cartilage proteoglycan degradation products in synovial fluids of patients with arthritis. Arthritis Rheum (1987) 1.41
Analysis of nucleotide pools in animal cells. Methods Cell Biol (1973) 1.41
Quantitative determination of gamma-carboxyglutamic acid in proteins. Anal Biochem (1977) 1.40
Identification of core protein, an intermediate in proteoglycan biosynthesis in cultured chondrocytes from the Swarm rat chondrosarcoma. J Biol Chem (1981) 1.35
Characterization of a thiol proteinase secreted by malignant human breast tumours. Biochim Biophys Acta (1980) 1.33
Carboxylated calcium-binding proteins and vitamin K. N Engl J Med (1980) 1.31
An analysis of 14 molecular markers for monitoring osteoarthritis: segregation of the markers into clusters and distinguishing osteoarthritis at baseline. Osteoarthritis Cartilage (2000) 1.29
Immunoinhibition of intracellular protein digestion in macrophages. J Exp Med (1973) 1.29
Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts. J Bone Miner Res (2002) 1.29
Association of an extracellular protein (chondrocalcin) with the calcification of cartilage in endochondral bone formation. J Cell Biol (1984) 1.28
Action of concanavalin A on the attachment stage of phagocytosis by macrophages. Exp Cell Res (1971) 1.28
Age-related changes in cartilage proteoglycans: quantitative electron microscopic studies. Microsc Res Tech (1994) 1.27
Localization of a dermatan sulfate proteoglycan (DS-PGII) in cartilage and the presence of an immunologically related species in other tissues. J Histochem Cytochem (1986) 1.26
Secretion of proteinases from malignant and nonmalignant human breast tissue. Cancer Res (1980) 1.25
Role of proteoglycans in endochondral ossification: immunofluorescent localization of link protein and proteoglycan monomer in bovine fetal epiphyseal growth plate. J Cell Biol (1982) 1.25
Proteoglycans from bovine nasal cartilage. Immunochemical studies of link protein. J Biol Chem (1980) 1.24
Proteoglycans and glycosaminoglycans induce gap junction synthesis and function in primary liver cultures. J Cell Biol (1987) 1.24
Age-related changes in protein-related epitopes of human articular-cartilage proteoglycans. Biochem J (1986) 1.24
Altered distribution of lysosomal cathepsin D in ischemic myocardium. J Clin Invest (1977) 1.21
The extracellular matrix of cartilage in the growth plate before and during calcification: changes in composition and degradation of type II collagen. Calcif Tissue Int (1992) 1.21
Osteopontin posttranslational modifications, possibly phosphorylation, are required for in vitro bone resorption but not osteoclast adhesion. Bone (2002) 1.21
Binding of calcium to SP-A, a surfactant-associated protein. Biochemistry (1990) 1.19
Extracellular presence of the lysosomal proteinase cathepsin B in rheumatoid synovium and its activity at neutral pH. Arthritis Rheum (1984) 1.17
Lysosomal alterations in hypoxic and reoxygenated hearts. II. Immunohistochemical and biochemical changes in cathepsin D. Am J Pathol (1980) 1.17
Proteoglycan-induced polyarthritis and spondylitis adoptively transferred to naive (nonimmunized) BALB/c mice. Arthritis Rheum (1990) 1.17
The induction of arthritis in mice by the cartilage proteoglycan aggrecan: roles of CD4+ and CD8+ T cells. Cell Immunol (1992) 1.17
Early post-traumatic osteoarthritis-like changes in human articular cartilage following rupture of the anterior cruciate ligament. Osteoarthritis Cartilage (2005) 1.16
Localisation of plasma alpha2HS glycoprotein in mineralising human bone. Nature (1975) 1.16
The proteoglycan decorin binds C1q and inhibits the activity of the C1 complex. J Immunol (1992) 1.16
Fibronectin-mediated adhesion of fibroblasts: inhibition by dermatan sulfate proteoglycan and evidence for a cryptic glycosaminoglycan-binding domain. J Cell Biol (1987) 1.16
Isolation and characterization of a 35,000 molecular weight subunit fetal cartilage matrix protein. J Biol Chem (1983) 1.16
Unsuitability of leucine naphthylamide for the histochemical demonstration of lysosomal proteolytic activity. Nature (1969) 1.15
Structural changes during development in bovine fetal epiphyseal cartilage. Coll Relat Res (1981) 1.15
Cathepsin D in cartilage: the immunohistochemical demonstration of extracellular enzyme in normal and pathological conditions. J Cell Sci (1974) 1.15
Type II collagen degradation in articular cartilage fibrillation after anterior cruciate ligament transection in rats. Osteoarthritis Cartilage (2001) 1.14
Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis. Arthritis Rheum (2001) 1.14
The primary structure of the core protein of the small, leucine-rich proteoglycan (PG I) from bovine articular cartilage. J Biol Chem (1989) 1.13
A novel angiogenic molecule produced at the time of chondrocyte hypertrophy during endochondral bone formation. Dev Biol (1996) 1.13
The human lumbar endplate. Evidence of changes in biosynthesis and denaturation of the extracellular matrix with growth, maturation, aging, and degeneration. Spine (Phila Pa 1976) (1996) 1.12
Mammalian eyes and associated tissues contain molecules that are immunologically related to cartilage proteoglycan and link protein. J Cell Biol (1982) 1.12
Elevation of a collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dog. Osteoarthritis Cartilage (2002) 1.11
Secretion and localization of cathepsin D in synovial tissues removed from rheumatoid and traumatized joints. An immunohistochemical study. Arthritis Rheum (1977) 1.11
Lymphocyte transformation to connective tissue antigens in adult and juvenile rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, systemic lupus erythematosus, and a nonarthritic control population. Cell Immunol (1983) 1.11
Chondrogenesis in periosteal explants. An organ culture model for in vitro study. J Bone Joint Surg Am (1994) 1.10
Proteoglycans from bovine proximal humeral articular cartilage. J Biol Chem (1973) 1.10